Published in Bull Exp Biol Med on September 27, 2014
[Significance of cardiac cannabinoid receptors in regulation of cardiac rhythm, myocardial contractility, and electrophysiologic processes in heart]. Izv Akad Nauk Ser Biol (2007) 0.99
Role of cannabinoid receptors in the regulation of cardiac contractility during ischemia/reperfusion. Bull Exp Biol Med (2006) 0.83
Selective cannabinoid receptor agonist HU-210 decreases pump function of isolated perfused heart: role of cAMP and cGMP. Bull Exp Biol Med (2004) 0.79
Activation of cannabinoid receptors decreases the area of ischemic myocardial necrosis. Bull Exp Biol Med (2002) 0.78
Opioid peptide deltorphin II simulates the cardioprotective effect of ischemic preconditioning: role of δ₂-opioid receptors, protein kinase C, and K(ATP) channels. Bull Exp Biol Med (2010) 0.78
Cardioprotective effect of kappa1-opioid receptor activation and role of cAMP in its realization. Bull Exp Biol Med (2007) 0.78
Scintigraphic visualization of bacterial translocation in experimental strangulated intestinal obstruction. Eur J Nucl Med Mol Imaging (2009) 0.78
Activation of peripheral delta opioid receptors eliminates cardiac electrical instability in a rat model of post-infarction cardiosclerosis via mitochondrial ATP-dependent K+ channels. Life Sci (2003) 0.77
[Antiarrhythmic effect of the antiopioid peptide nociceptin and its effect on fast Na+-channels in cardiomyocytes]. Biull Eksp Biol Med (1998) 0.77
Negative inotropic and chronotropic effects of delta-opioid receptor antagonists are mediated via non-opioid receptors. Bull Exp Biol Med (2006) 0.77
Effect of stress adaptation on cyclic nucleotide content in myocardial tissue during acute ischemia/reperfusion. Bull Exp Biol Med (2008) 0.77
[Role of delta opioid receptors and their ligands in the development of adaptive heart protection against arrhythmogenesis]. Ross Fiziol Zh Im I M Sechenova (2001) 0.77
[The anti-arrhythmia and pro-arrhythmia properties of sigma-receptor ligands]. Eksp Klin Farmakol (2000) 0.76
[Ischemic postconditioning of the heart. Receptor mechanisms and possibility of clinical use]. Kardiologiia (2010) 0.76
[Specificity of the anti-arrhythmic effect of kappa1-opioid receptor agonists]. Eksp Klin Farmakol (2001) 0.76
[Effect of a Rhodiolae rosea extract on the level of inducible HSP-70 in the myocardium under stress]. Biull Eksp Biol Med (1996) 0.76
Receptor specificity of the antiarrhythmic effect produced by opioid peptides Dalargin and DADLE during myocardial reperfusion. Bull Exp Biol Med (2002) 0.76
Antiarrhythmic activity of phytoadaptogens in short-term ischemia-reperfusion of the heart and postinfarction cardiosclerosis. Bull Exp Biol Med (2009) 0.76
[Significance of opioid receptors in regulation of cardiac tolerance in pathogenic impact of long-term ischemia-reperfusion in vivo]. Ross Fiziol Zh Im I M Sechenova (2009) 0.75
[Perspective of creation of drugs on basis of opioids increasing cardiac tolerance to pathogenic impact of ischemia reperfusion]. Eksp Klin Farmakol (2012) 0.75
[Interactions of peripheral mu-opioid receptors and K(ATP)-channels in regulation of cardiac electrical stability in ischemia, reperfusion, and postinfarction cardiosclerosis]. Ross Fiziol Zh Im I M Sechenova (2002) 0.75
[Antiarrhythmic and cardioprotective effect of stimulation of delta1-opiate receptors in myocardial ischemia and reperfusion]. Patol Fiziol Eksp Ter (2004) 0.75
[Ligands of opioid and sigma receptors and correction of cardiac electrical instability in post-infarction cardiosclerosis]. Eksp Klin Farmakol (2001) 0.75
Cardioprotective effect of ischemic postconditioning on the model of isolated heart. Bull Exp Biol Med (2012) 0.75
[Opiatergic mechanisms of antiarrhythmic effect of adaptation]. Biull Eksp Biol Med (1996) 0.75
Possible mechanism underlying the antiarrhythmic effect of peptides nociceptin and DALDA on the heart. Bull Exp Biol Med (2003) 0.75
[Participation of endogenous mu- and delta-opiate receptor agonists in mechanisms of the anti-arrhythmia effect of adaptation]. Biull Eksp Biol Med (1996) 0.75
[Perspective of use of agonists of adenosine and opioid receptors for prevention of reperfusion damages of heart. Analysis of experimental and clinical data]. Vestn Ross Akad Med Nauk (2014) 0.75
Role of endogenous opioid receptor agonists in regulation of heart resistance to the arrhythmogenic action of short-term ischemia and reperfusion. Bull Exp Biol Med (2005) 0.75
[Myocardial tolerance to arrhythmogenic exposure and pharmacological activation of K(ATP)-channels in rats]. Eksp Klin Farmakol (2001) 0.75
Myocardial resistance to ischemic and reperfusion injuries under conditions of chronic administration of opioid receptor agonists and antagonists. Bull Exp Biol Med (2008) 0.75
[STRESS AND INFARCT LIMITING EFFECTS OF EARLY HYPOXIC PRECONDITIONING]. Ross Fiziol Zh Im I M Sechenova (2015) 0.75
Antihypoxic, cardioprotective, and antifibrillation effects of a combined adaptogenic plant preparation. Bull Exp Biol Med (2006) 0.75
[The participation of the central and peripheral kappa-opiate receptors in the mechanism of the anti-arrhythmia action of benzeneacetamide derivatives]. Eksp Klin Farmakol (1997) 0.75
[Alterations of inotropic function of isolated heart and extent of injury of cardiomyocytes after cannabinoid receptor activation during ischemia and reperfusion]. Ross Fiziol Zh Im I M Sechenova (2003) 0.75
[The role of cnetral and peripheral mu and delta opiate receptors in the realization of the anti-arrhythymic effect of adaptation]. Biull Eksp Biol Med (1996) 0.75
[Anti-arrhythmic effect of the sigma-receptor blocker DuP 734 in ischemia and myocardial reperfusion]. Eksp Klin Farmakol (2001) 0.75
[The role of the mu and delta types of the peripheral opiate receptors in regulating cardiac resistance to arrhythmogenic actions]. Ross Fiziol Zh Im I M Sechenova (1997) 0.75
[Role of ORL1 receptors in the regulation of cardiac resistance to arrhythmogenic effects ]. Ross Fiziol Zh Im I M Sechenova (2003) 0.75
[Stimulation of peripheral delta1-opioid receptors as a method of preventing ischemic and reperfusion arrhythmia: role of K(ATP)-channels]. Eksp Klin Farmakol (2002) 0.75
[The role of opiate receptors and ATP-dependent potassium channels of mitochondria in the formation of myocardial adaptive resistance to the arrhythmogenic effect of ischemia and reperfusion]. Izv Akad Nauk Ser Biol (2004) 0.75
[The effect of calmodulin inhibitors and the new cardiotonic drug DPI 201-106 on the formation of interprotein bonds in the cardiac troponin complex]. Biokhimiia (1990) 0.75
[Endogenic opioid peptides and antiarrhythmic effect of adaptation to stress]. Patol Fiziol Eksp Ter (2004) 0.75
The anti-arrhythmia properties of the functional opioid agonist orphanin FQ (nociceptin). Eksp Klin Farmakol (1999) 0.75
[The anti-arrhythmic activity of agonists of the peripheral mu-opiate receptors]. Eksp Klin Farmakol (1999) 0.75
Role of ATP-sensitive K(+)-channels in antiarrhythmic and cardioprotective action of adaptation to intermittent hypobaric hypoxia. Bull Exp Biol Med (2008) 0.75
[The use of opiate receptor ligands for correction of heart electrical instability]. Biull Eksp Biol Med (1998) 0.75
Drug interaction with cardiac and skeletal muscle troponin C. Biomed Sci (1990) 0.75
[Mediated role of NO-syntase, protein kinase C and KATP-channels in realization of cardioprotective impact of cannabinoid HU-210]. Eksp Klin Farmakol (2012) 0.75
[PROBLEM OF END EFFECTOR OF ISCHEMIC POSTCONDITIONING OF THE HEART]. Ross Fiziol Zh Im I M Sechenova (2015) 0.75
[Determination of the efficiency of single-photon emission computed tomography with 99mTc-HMPAO-labelled leukocytes in the diagnosis of myocarditis: Comparison of scintigraphic and histological data]. Vestn Rentgenol Radiol (2015) 0.75
[The mechanism of the anti-arrhythmia action of mu-opioid-receptor agonists in a model of CaCl2-induced arrhythmias: the role of the autonomic nervous system]. Eksp Klin Farmakol (1997) 0.75
[The anti-arrhythmic effect of the mu-opiate receptor agonists in adrenal arrhythmia: the role of the autonomic nervous system]. Biull Eksp Biol Med (1996) 0.75
Comparative analysis of early and delayed cardioprotective and antiarrhythmic efficacy of hypoxic preconditioning. Bull Exp Biol Med (2014) 0.75
[INVOLVEMENT OF NO-SYNTHASE IN THE INFARCT REDUCING EFFECT OF CONTINUOUS CHRONIC NORMOBARTC HYPOXTA]. Ross Fiziol Zh Im I M Sechenova (2015) 0.75
Analysis of mechanisms of interaction between ciprofloxacin-based radiopharmaceutical labeled with technetium-99m and cultured Staphylococcus aureus. Bull Exp Biol Med (2014) 0.75
[Receptor and signalling mechanisms of antiarrhythmic effects of ischemic pre-conditioning]. Ross Fiziol Zh Im I M Sechenova (2013) 0.75
Contribution of Opioid Receptors to the Cytoprotective Effect of the Adaptation to Chronic Hypoxia at Anoxia/Reoxygenation of Isolated Cardiomyocytes. Bull Exp Biol Med (2015) 0.75
[Changes in cardiac resistance to arrhythmogenic effects during ATP-dependent K+ channel activation]. Ross Fiziol Zh Im I M Sechenova (2003) 0.75
Transplantation of bone marrow mononuclear cells does not affect postinfarction electrical remodeling of the heart. Bull Exp Biol Med (2008) 0.75
[Peripheral mu-opiate receptors and regulation of cardiac resistance to arrhythmogenic effects]. Biull Eksp Biol Med (1998) 0.75
[Cardioprotective, inotropic, and anti-arrhythmia properties of a complex adaptogen "Tonizid"]. Eksp Klin Farmakol (2008) 0.75
[Preconditioning impact on coronary perfusion during ischemia and reperfusion of heart]. Ross Fiziol Zh Im I M Sechenova (2012) 0.75
[Delta-opiate receptors and heart resistance to arrhythmogenic factors]. Ross Fiziol Zh Im I M Sechenova (1998) 0.75
[Phytoadaptogens-induced phenomenon similar to ischemic preconditioning]. Ross Fiziol Zh Im I M Sechenova (2009) 0.75
Variability of the biological activity of oxidized titanium implants. Bull Exp Biol Med (2012) 0.75
[Endogenous opioid system and resistance of the heart against arrhythmogenic influences]. Kardiologiia (2002) 0.75
Effect of in vivo and in vitro stimulation of delta1-opioid receptors on myocardial resistance to arrhythmogenic action of ischemia and reperfusion. Bull Exp Biol Med (2002) 0.75
Inotropic and chronotropic effects of ischemic postconditioning on the model of isolated heart. Bull Exp Biol Med (2012) 0.75
[Role of cannabinoid receptors in regulation of cardiac tolerance to ischemia and reperfusion]. Izv Akad Nauk Ser Biol (2008) 0.75
[Participation of inducible stress-proteins in realizing the cardioprotective effect of Rhodiolae rosea]. Biokhimiia (1996) 0.75
[Paticipation of cannabinoid receptors in the regulation of cardiac rhythm and cardiac contractility]. Ross Fiziol Zh Im I M Sechenova (2006) 0.75
[Signaling mechanism of cardioprotective effects of opioids]. Eksp Klin Farmakol (2013) 0.75
[Intracellular mechanisms of cardioprotection during adaptation to hypoxia. Triggers and kinase cascades]. Ross Fiziol Zh Im I M Sechenova (2011) 0.75
[The mechanism of antiarrhythmic action of the endogenous ORL1 receptor agonist nociceptin]. Eksp Klin Farmakol (2005) 0.75
[The anti-arrhythmic effect of the selective sigma-receptor antagonist DuP 734 [1-(cyclopropylmethyl)-4-(2'-(4''-fluorophenyl)-2'-oxoethyl)piper idine HBr]]. Eksp Klin Farmakol (1997) 0.75
[Effect of calcium ions on the interaction of troponin C with rabbit skeletal muscle troponin I and troponin T immobilized on polyvinyl chloride]. Biokhimiia (1989) 0.75
[Role of receptor transactivation in the cardioprotective effects of preconditioning and postconditioning]. Ross Fiziol Zh Im I M Sechenova (2012) 0.75
[Modulation of the antiarrhythmic effect by endogenous opioids during adaptation to hypoxia in rats]. Ross Fiziol Zh Im I M Sechenova (1998) 0.75
[MIMICKING ISCHEMIC PRECONDITIONING PHENOMENON THROUGH THE IMPACT ON THE CANNABINOID RECEPTORS: ROLE OF PROTEIN KINASE AND NO-SYNTHASE]. Ross Fiziol Zh Im I M Sechenova (2015) 0.75